Calamos Advisors »

Lb Pharmaceuticals shares owned by Calamos Advisors

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $593k 24k 24.66

More positions owned by Calamos Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Western Digital Corp Note 3.000%11/1 (Principal)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Calamos Advisors

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
TCG Crossover Management
Commodore Capital
Trails Edge Capital Partners
Vanguard Group
Nantahala Capital Management
Balyasny Asset Management
Logos Global Management
Vanguard Capital Management
Alyeska Investment Group
Vivo Capital
Jennison Associates
Geode Capital Management

View all funds holding Lb Pharmaceuticals